Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

Nature volume 458, pages 771–775 (2009)Cite this article

Abstract

Reprogramming of somatic cells to pluripotency, thereby creating induced pluripotent stem (iPS) cells, promises to transform regenerative medicine. Most instances of direct reprogramming have been achieved by forced expression of defined factors using multiple viral vectors1,2,3,4,5,6,7. However, such iPS cells contain a large number of viral vector integrations1,8, any one of which could cause unpredictable genetic dysfunction. Whereas c-Myc is dispensable for reprogramming9,10, complete elimination of the other exogenous factors is also desired because ectopic expression of either Oct4 (also known as Pou5f1) or Klf4 can induce dysplasia11,12. Two transient transfection-reprogramming methods have been published to address this issue13,14. However, the efficiency of both approaches is extremely low, and neither has been applied successfully to human cells so far. Here we show that non-viral transfection of a single multiprotein expression vector, which comprises the coding sequences of c-Myc, Klf4, Oct4 and Sox2 linked with 2A peptides, can reprogram both mouse and human fibroblasts. Moreover, the transgene can be removed once reprogramming has been achieved. iPS cells produced with this non-viral vector show robust expression of pluripotency markers, indicating a reprogrammed state confirmed functionally by in vitro differentiation assays and formation of adult chimaeric mice. When the single-vector reprogramming system was combined with a piggyBac transposon15,16, we succeeded in establishing reprogrammed human cell lines from embryonic fibroblasts with robust expression of pluripotency markers. This system minimizes genome modification in iPS cells and enables complete elimination of exogenous reprogramming factors, efficiently providing iPS cells that are applicable to regenerative medicine, drug screening and the establishment of disease models.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Efficient reactivation of pluripotent markers in iPS cells generated by a non-viral multiprotein expression vector.
Figure 2: Non-viral iPS cells with a single-vector integration site.
Figure 3: Reprogramming cassette excision and pluripotency of the non-viral iPS cells.

References

  1. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006)

    Article  CAS  Google Scholar 

  2. Wernig, M. et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318–324 (2007)

    Article  ADS  CAS  Google Scholar 

  3. Maherali, N. et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1, 55–70 (2007)

    Article  CAS  Google Scholar 

  4. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007)

    Article  CAS  Google Scholar 

  5. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007)

    Article  ADS  CAS  Google Scholar 

  6. Park, I. H. et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141–146 (2008)

    Article  ADS  CAS  Google Scholar 

  7. Okita, K., Ichisaka, T. & Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 448, 313–317 (2007)

    Article  ADS  CAS  Google Scholar 

  8. Aoi, T. et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321, 699–702 (2008)

    Article  ADS  CAS  Google Scholar 

  9. Nakagawa, M. et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotechnol. 26, 101–106 (2008)

    Article  CAS  Google Scholar 

  10. Wernig, M., Meissner, A., Cassady, J. P. & Jaenisch, R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2, 10–12 (2008)

    Article  CAS  Google Scholar 

  11. Hochedlinger, K., Yamada, Y., Beard, C. & Jaenisch, R. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121, 465–477 (2005)

    Article  CAS  Google Scholar 

  12. Foster, K. W. et al. Induction of KLF4 in basal keratinocytes blocks the proliferation–differentiation switch and initiates squamous epithelial dysplasia. Oncogene 24, 1491–1500 (2005)

    Article  CAS  Google Scholar 

  13. Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G. & Hochedlinger, K. Induced pluripotent stem cells generated without viral integration. Science 322, 954–959 (2008)

    Article  ADS  Google Scholar 

  14. Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T. & Yamanaka, S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322, 949–953 (2008)

    Article  ADS  CAS  Google Scholar 

  15. Wang, W. et al. Chromosomal transposition of PiggyBac in mouse embryonic stem cells. Proc. Natl Acad. Sci. USA 105, 9290–9295 (2008)

    Article  ADS  CAS  Google Scholar 

  16. Woltjen, K. et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 10.1038/nature07863 (this issue)

  17. Hasegawa, K., Cowan, A. B., Nakatsuji, N. & Suemori, H. Efficient multicistronic expression of a transgene in human embryonic stem cells. Stem Cells 25, 1707–1712 (2007)

    Article  CAS  Google Scholar 

  18. Szymczak, A. L. et al. Correction of multi-gene deficiency in vivo using a single ‘self-cleaving’ 2A peptide-based retroviral vector. Nature Biotechnol. 22, 589–594 (2004)

    Article  CAS  Google Scholar 

  19. Sommer, C. A. et al. iPS cell generation using a single lentiviral stem cell cassette. Stem Cells 10.1634/stemcells.2008–1075 (2008)

  20. Carey, B. W. et al. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc. Natl Acad. Sci. USA 106, 157–162 (2009)

    Article  ADS  CAS  Google Scholar 

  21. Niwa, H., Yamamura, K. & Miyazaki, J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193–199 (1991)

    Article  CAS  Google Scholar 

  22. Yeh, E. et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nature Cell Biol. 6, 308–318 (2004)

    Article  CAS  Google Scholar 

  23. Chambers, I. et al. Nanog safeguards pluripotency and mediates germline development. Nature 450, 1230–1234 (2007)

    Article  ADS  CAS  Google Scholar 

  24. Mikkelsen, T. S. et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 454, 49–55 (2008)

    Article  ADS  CAS  Google Scholar 

  25. Kunath, T. et al. FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development 134, 2895–2902 (2007)

    Article  CAS  Google Scholar 

  26. Kaji, K. et al. The NuRD component Mbd3 is required for pluripotency of embryonic stem cells. Nature Cell Biol. 8, 285–292 (2006)

    Article  CAS  Google Scholar 

  27. Ying, Q. L., Stavridis, M., Griffiths, D., Li, M. & Smith, A. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nature Biotechnol. 21, 183–186 (2003)

    Article  CAS  Google Scholar 

  28. Brueckner, B., Kuck, D. & Lyko, F. DNA methyltransferase inhibitors for cancer therapy. Cancer J. 13, 17–22 (2007)

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank A. Tsakiridis for advice on using the 2A peptide sequence and A. Nagy for providing data from his laboratory on generating human reprogrammed cell lines by combining the PB transposon system and the 2A-sequence-joined reprogramming factors (or MKOS single vector reprogramming system) as well as for his comments on the manuscript. We also thank I. Chambers for providing TNG MEFs and for discussion and comments on the manuscript, V. Wilson for advice on teratoma analysis, T. Kunath, S. Lowell, C. Blackburn and K. Vintersten for discussions and comments on the manuscript, and B. Hendrich for permission to start preliminary experiments of this work in his laboratory. We also thank J. Ure, L. Robertson, R. McLay and R. Wilkie for technical assistance, and Biomed unit staff for mouse husbandry. K.K. is the recipient of MRC career development fellowship in stem cell research. A.P. is the recipient of a BBSRC CASE PhD studentship. M.M., P.M. and K.W. were supported by grants from the Canadian Stem Cell Network and Juvenile Diabetes Research Foundation.

Author Contributions K.K. conceived the study, designed and executed the experiments, interpreted data and wrote the manuscript. K.N. performed immunoblotting and karyotype checking, and assisted with manuscript preparation. A.P. performed real-time PCR and in vitro differentiation experiments. M.M. generated human reprogrammed cells. P.M. performed immunostaining for human reprogrammed cells. K.W. constructed the PB/MKOS system, assisted human cell reprogramming experiments and analysis, and helped to prepare the manuscript.

Author information

Authors and Affiliations

  1. MRC Centre for Regenerative Medicine, Institute for Stem Cell Research, University of Edinburgh, Edinburgh EH9 3JQ, UK

    Keisuke Kaji, Katherine Norrby & Agnieszka Paca

  2. Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada ,

    Maria Mileikovsky, Paria Mohseni & Knut Woltjen

  3. Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada,

    Paria Mohseni

Authors
  1. Keisuke Kaji
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katherine Norrby
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Agnieszka Paca
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Mileikovsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Paria Mohseni
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Knut Woltjen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Keisuke Kaji.

Supplementary information

Supplementary Information

This file contains Supplementary Figures 1-10 with Legends, Supplementary Tables 1-5 and Supplementary Methods (PDF 4717 kb)

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kaji, K., Norrby, K., Paca, A. et al. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458, 771–775 (2009). https://doi.org/10.1038/nature07864

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature07864

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing